Loading...
XSHE
300381
Market cap466mUSD
Dec 05, Last price  
6.87CNY
1D
0.73%
1Q
-4.45%
Jan 2017
-71.28%
IPO
-6.66%
Name

Guangdong VTR Bio-Tech Co Ltd

Chart & Performance

D1W1MN
XSHE:300381 chart
P/E
106.12
P/S
3.99
EPS
0.06
Div Yield, %
0.87%
Shrs. gr., 5y
1.77%
Rev. gr., 5y
-16.60%
Revenues
826m
+3.79%
85,691,585147,241,060179,871,044216,863,387270,454,522337,425,697359,159,329359,816,415703,472,7171,512,440,9921,499,263,3221,768,167,8082,048,133,4041,914,764,4581,892,160,3361,174,006,689796,021,979826,201,215
Net income
31m
P
11,507,25219,511,73824,486,13928,184,23343,176,16554,714,63963,134,79355,122,79171,829,414113,566,05980,424,345113,508,486127,522,059161,706,004018,232,003-10,749,72031,091,854
CFO
69m
-55.19%
0025,638,50035,345,07553,500,47061,319,05067,911,39817,959,69154,158,88500203,948,204442,165,361403,726,106216,929,263249,773,827154,399,92869,192,704
Dividend
Jun 18, 20240.06 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.
IPO date
Jan 28, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT